|
Yeah, but get this. Last year, if you check SEC filings, alot of the CEO's of the company loaded up with stock options. Obscene amounts of stock options, because they believed last spring was going to be the springboard for the stock. So management has faith in the drug, however blind that may be. They have not mislead investors, as far as I know. Not to say, investors have been taken out and shot twice in this stock so far, so it is dangerous. But then again, it's usually when things look the worst that the opposite happens. True? Heck, look at earnings warnings this spring, >warn, and the stock goes up.>??? So, with FDA recommending everything this year at an astonishing rate, I just think it's worth a shot. Speaking of being shot....I've managed to catch the very top of a large selloff in Broderbund and Oracle this week, erasing half of my NN 50% gain this year....so I've not been the luckiest guy in the world recently. I'm buying calls, perhaps the wise out there should buy puts. |
